ASPIRA PATHLAB & DIAGNOSTICS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Aspira Pathlab & Diagnostics along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-3.01₹ -2.02
As on Dec 17, 2025, 4:01 PM IST
Aspira Pathlab & Diagnostics Price Performance
Today's LowToday's High
₹62.81₹65.50
₹65.01
52 Weeks' Low52 Weeks' High
₹50.49₹106.78
₹65.01
Open Price
₹65.01
Prev. Close
₹67.03
Volume
442
Over the last 5 years, the share price of Aspira Pathlab & Diagnostics has gained 20.58% CAGR. Over the past year, the corresponding return has been 0.40%.
Aspira Pathlab & Diagnostics’s current P/E of 27.91x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Aspira Pathlab & Diagnostics Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Aspira Pathlab & Diagnostics | -2.24 | 8.35 | 0.02 | 9.91 | 0.40 | 15.09 | 20.58 |
| Max Healthcare Institute | -4.00 | -7.86 | -10.38 | -15.63 | -14.45 | 34.52 | 49.33 |
| Apollo Hospitals Enterprise | -1.45 | -7.63 | -12.23 | -1.25 | -4.24 | 14.47 | 23.55 |
| Fortis Healthcare | 2.23 | -7.64 | -9.42 | 14.45 | 26.89 | 46.17 | 40.71 |
| Narayana Hrudayalaya | 0.70 | -7.74 | 3.57 | -1.66 | 44.52 | 35.25 | 35.22 |
| Aster DM Healthcare | -3.30 | -10.16 | -0.85 | 7.27 | 24.89 | 40.16 | 29.64 |
| Global Health | -1.48 | -5.29 | -17.28 | -3.84 | 2.81 | 36.81 | 22.37 |
| Krishna Institute of Medical Sciences | -2.70 | -4.71 | -13.18 | -2.24 | 8.13 | 29.98 | 26.50 |
| Dr. Lal Pathlabs | -1.79 | -10.64 | -13.41 | -3.58 | -6.71 | 7.34 | 5.53 |
| Dr. Agarwals Health Care | 1.61 | -3.44 | 13.56 | 26.37 | 24.31 | 7.52 | 4.45 |
| Rainbow Childrens Medicare | -3.41 | 0.62 | -9.68 | -7.25 | -17.30 | 20.94 | 23.93 |
| Healthcare Global Enterprises | 0.03 | -3.34 | 5.75 | 31.30 | 34.83 | 33.53 | 33.21 |
| Vijaya Diagnostic Centre | -3.96 | -6.16 | -7.19 | 2.71 | -8.53 | 31.13 | 9.49 |
| Metropolis Healthcare | -1.57 | -4.50 | -7.65 | 11.91 | -12.91 | 13.75 | -0.30 |
| Jupiter Life Line Hospitals | -0.42 | -3.09 | -3.29 | -7.72 | -10.04 | 9.43 | 5.56 |
| Thyrocare Technologies | 4.55 | -14.96 | 9.87 | 32.12 | 33.50 | 29.53 | 6.59 |
| Yatharth Hospital & Trauma Care Services | -1.31 | -15.39 | -15.95 | 29.35 | 11.12 | 26.32 | 15.05 |
| Kovai Medical Center and Hospital | -2.56 | -3.57 | -6.90 | 0.60 | -0.05 | 51.00 | 41.43 |
| Artemis Medicare Services | 0.86 | 2.10 | 14.46 | 10.12 | -15.33 | 52.86 | 65.51 |
| Indraprastha Medical Corporation | 3.93 | -14.66 | -2.63 | 15.17 | -6.92 | 77.99 | 50.98 |
Over the last one year, Aspira Pathlab & Diagnostics has gained 0.40% compared to peers like Max Healthcare Institute (-14.45%), Apollo Hospitals Enterprise (-4.24%), Fortis Healthcare (26.89%). From a 5 year perspective, Aspira Pathlab & Diagnostics has underperformed peers relative to Max Healthcare Institute (49.33%) and Apollo Hospitals Enterprise (23.55%).
Aspira Pathlab & Diagnostics Financials
Aspira Pathlab & Diagnostics Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 68.34 | 67.5 |
| 10 | 68.33 | 67.55 |
| 20 | 67 | 66.81 |
| 50 | 64.7 | 65.21 |
| 100 | 63.92 | 64.11 |
| 200 | 64.65 | 62.49 |
Aspira Pathlab & Diagnostics Share Holding Pattern
In the latest quarter, Aspira Pathlab & Diagnostics remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 81.61% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Aspira Pathlab & Diagnostics Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 13, 2025, 3:06 AM IST | Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Nov 13, 2025, 2:49 AM IST | Aspira Pathlab & Dia - Standalone Financial Results And Limited Review Report As On September 30, 2025 |
| Nov 13, 2025, 1:53 AM IST | Aspira Pathlab & Dia - Board Meeting Outcome for Outcome Of Board Meeting Held On November 12, 2025 |
| Nov 05, 2025, 12:21 AM IST | Aspira Pathlab & Dia - Board Meeting Intimation for The Board Meeting To Be Held On November 12, 2025 |
| Oct 14, 2025, 12:58 AM IST | Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Open Offer - Updates |
About Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics Ltd. is a Public Limited Listed company incorporated on 03/07/1973 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L85100MH1973PLC289209 and registration number is 289209. Currently Company is involved in the business activities of Other human health activities. Company's Total Operating Revenue is Rs. 22.00 Cr. and Equity Capital is Rs. 10.29 Cr. for the Year ended 31/03/2025.
- IndustryHospitals & Medical Services
- AddressFlat No.2, R.D. Shah Building, Mumbai Maharashtra 400086
- Contact
Management
- Dr. Haseeb A DrabuChairman & Ind.Director
- Dr. Pankaj J ShahManaging Director & CEO
- Mr. Nikunj V MangeExecutive Director
- Mrs. Mangala R PrabhuIndependent Director
- Dr. Manas R MengarIndependent Director
FAQs on Aspira Pathlab & Diagnostics Share Price
What is the share price of Aspira Pathlab & Diagnostics?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Aspira Pathlab & Diagnostics is ₹65.01 as on Dec 17, 2025.
What kind of stock is Aspira Pathlab & Diagnostics?
The Aspira Pathlab & Diagnostics is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Aspira Pathlab & Diagnostics?
The market cap of Aspira Pathlab & Diagnostics is ₹66.91 Cr as on Dec 17, 2025.
What are today's High and Low prices of Aspira Pathlab & Diagnostics?
Today’s highest and lowest price of Aspira Pathlab & Diagnostics are ₹65.50 and ₹62.81.
What are the 52 Week High and 52 Week Low of Aspira Pathlab & Diagnostics?
The 52-week high/low is the highest and lowest price at which Aspira Pathlab & Diagnostics stock has traded in the past 52-week or nearly a year. The 52-week high of Aspira Pathlab & Diagnostics is ₹106.78 and 52-week low of Aspira Pathlab & Diagnostics is ₹50.49 as on Dec 17, 2025.
How has the Aspira Pathlab & Diagnostics performed historically in terms of returns?
The Aspira Pathlab & Diagnostics has shown returns of -3.01% over the past day, 8.35% for the past month, 0.02% over 3 months, 0.4% over 1 year, 15.09% across 3 years, and 20.58% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Aspira Pathlab & Diagnostics?
P/E ratio of and PB ratio of Aspira Pathlab & Diagnostics are 27.91 and 9.25 on Dec 17, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse